2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6247 | Onvansertib | NMS-P937,NMS-1286937 | Apoptosis , PLK |
Onvansertib (NMS-1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3. | |||
T71085 | BMS-824 | ||
BMS-824 is a potent NS5A inhibitor. The 50% inhibition of HCV replicon replication for BMS-824 was approximately 5 nM, with a therapeutic index of >10,000. BMS-824 showed good specificity for HCV, as it was not active... |